Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Sagimet Biosciences Inc (NASDAQ: SGMT) was $5.83 for the day, down -2.67% from the previous closing price of $5.99. In other words, the price has decreased by -$2.67 from its previous closing price. On the day, 0.57 million shares were traded. SGMT stock price reached its highest trading level at $6.31 during the session, while it also had its lowest trading level at $5.74.
Ratios:
Our analysis of SGMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 29.11 and its Current Ratio is at 29.11. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on June 28, 2024, Downgraded its rating to Neutral and sets its target price to $6 from $23 previously.
On May 02, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $32.
On March 25, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $26.Leerink Partners initiated its Outperform rating on March 25, 2024, with a $26 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 23 ’24 when Kemble George sold 23,625 shares for $3.17 per share. The transaction valued at 74,830 led to the insider holds 118,693 shares of the business.
Martins Eduardo Bruno sold 8,357 shares of SGMT for $25,910 on Jul 19 ’24. The Chief Medical Officer now owns 81,213 shares after completing the transaction at $3.10 per share. On Jul 19 ’24, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,914 shares for $3.10 each. As a result, the insider received 33,830 and left with 160,506 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 193181712 and an Enterprise Value of 19837962. For the stock, the TTM Price-to-Sale (P/S) ratio is 93.86 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 9.919.
Stock Price History:
Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is 52.17%, while the 200-Day Moving Average is calculated to be 19.59%.
Shares Statistics:
SGMT traded an average of 1.33M shares per day over the past three months and 833010 shares per day over the past ten days. A total of 21.38M shares are outstanding, with a floating share count of 21.13M. Insiders hold about 34.36% of the company’s shares, while institutions hold 53.41% stake in the company. Shares short for SGMT as of 1728950400 were 3982642 with a Short Ratio of 3.00, compared to 1726185600 on 2065383. Therefore, it implies a Short% of Shares Outstanding of 3982642 and a Short% of Float of 14.78.